METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2021 | Series A | $86M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CMBI Zhaoxin Wuji Fund | — | Series A |